|
AU758679B2
(en)
*
|
1998-07-24 |
2003-03-27 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
|
WO2000007577A2
(de)
*
|
1998-08-06 |
2000-02-17 |
Wolfgang Stremmel |
Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
|
|
CZ20021076A3
(cs)
*
|
1999-09-28 |
2002-08-14 |
Panacea Biotec Limited |
Prostředky s kontrolovaným uvolňováním obsahující nimesulid
|
|
US7053076B2
(en)
|
2001-08-29 |
2006-05-30 |
Xenoport, Inc. |
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
|
|
WO2004042013A2
(en)
*
|
2002-11-01 |
2004-05-21 |
James Kaput |
Identification of diet-regulated disease-associated genes
|
|
CA2674683A1
(en)
*
|
2007-01-16 |
2008-07-24 |
The Burnham Institute For Medical Research |
Compositions and methods for treatment of colorectal cancer
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
MX386489B
(es)
|
2010-11-04 |
2025-03-19 |
Albireo Ab |
Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
|
|
KR20220082931A
(ko)
|
2014-06-25 |
2022-06-17 |
이에이 파마 가부시키가이샤 |
고형 제제 및 그의 착색 방지 또는 착색 감소 방법
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
CN111032019B
(zh)
|
2017-08-09 |
2022-07-05 |
阿尔比里奥公司 |
考来烯胺颗粒、口服考来烯胺制剂及其用途
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
ES2942443T3
(es)
|
2018-06-05 |
2023-06-01 |
Albireo Ab |
Compuestos de benzotia(di)azepina y su uso como moduladores de ácidos biliares
|
|
PT3810581T
(pt)
|
2018-06-20 |
2025-03-05 |
Albireo Ab |
Modificações cristalinas de odevixibat
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
GB201812382D0
(en)
|
2018-07-30 |
2018-09-12 |
Nzp Uk Ltd |
Compounds
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
PL3921028T3
(pl)
|
2019-02-06 |
2023-02-13 |
Albireo Ab |
Związki benzotiadiazepinowe i ich zastosowanie jako modulatory kwasów żółciowych
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
IL293379B1
(en)
|
2019-12-04 |
2025-12-01 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CA3158276A1
(en)
|
2019-12-04 |
2021-06-10 |
Per-Goran Gillberg |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CN114761080B
(zh)
|
2019-12-04 |
2024-07-23 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
EP4069247B1
(en)
|
2019-12-04 |
2025-03-26 |
Albireo AB |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
ES3002777T3
(en)
|
2020-08-03 |
2025-03-07 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
EP4243831A1
(en)
|
2020-11-12 |
2023-09-20 |
Albireo AB |
Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
|
|
BR112023010799A2
(pt)
|
2020-12-04 |
2023-10-03 |
Albireo Ab |
Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
|
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|